Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Carcinoembryonic Antigen

Out of Stock

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 209 days. Could come back at any time — we're watching for you.

Out of stock 209 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 659 days • 659 data points (No recent data available)

Historical
Generating forecast...
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 03 September 2024 14 February 2025 29 July 2025 09 January 2026 23 June 2026

Price Distribution

Price distribution over 659 days • 1 price levels

Days at Price
659 days 0 165 330 494 659 £790 Days at Price

Price Analysis

Most common price: £790 (659 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 659 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
22 April 2024

Similar Products You Might Like

The 2023-2028 World Outlook for Carcinoembryonic Antigen
99% match

The 2023-2028 World Outlook for Carcinoembryonic Antigen

£795.00 16 Jun 2026
The 2021-2026 World Outlook for Carcinoembryonic Antigens (CEA)
97% match

The 2021-2026 World Outlook for Carcinoembryonic Antigens (CEA)

Out of Stock 23 Jun 2026
The 2025-2030 World Outlook for Cancer Biomarkers
96% match

The 2025-2030 World Outlook for Cancer Biomarkers

Out of Stock 20 Jun 2026
The 2025-2030 World Outlook for Cancer Screenings
96% match

The 2025-2030 World Outlook for Cancer Screenings

Out of Stock 19 Jun 2026
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests
96% match

The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests

Out of Stock 20 Jun 2026
The 2025-2030 World Outlook for Cancer Specialty Hospitals
96% match

The 2025-2030 World Outlook for Cancer Specialty Hospitals

Out of Stock 23 Jun 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
95% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 11 Apr 2026
The 2023-2028 World Outlook for Cancer Diagnostics Laboratory Tests
95% match

The 2023-2028 World Outlook for Cancer Diagnostics Laboratory Tests

Out of Stock 16 Jun 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
95% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 17 Jun 2026
The 2025-2030 World Outlook for Next Generation Cancer Diagnostics
95% match

The 2025-2030 World Outlook for Next Generation Cancer Diagnostics

Out of Stock 17 Jun 2026
The 2025-2030 World Outlook for Cancer Therapies
95% match

The 2025-2030 World Outlook for Cancer Therapies

Out of Stock 17 Jun 2026
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in the United States
95% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in the United States

£520.00 17 Jun 2026
The 2021-2026 World Outlook for Cancer Biomarkers
95% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 18 Jun 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
95% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 14 Apr 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
95% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 18 Jun 2026
The 2023-2028 Outlook for Cancer Testing-Screening in China
95% match

The 2023-2028 Outlook for Cancer Testing-Screening in China

£495.00 16 Apr 2026
The 2025-2030 World Outlook for Blood Cancer Therapeutics
95% match

The 2025-2030 World Outlook for Blood Cancer Therapeutics

Out of Stock 18 Jun 2026
The 2025-2030 World Outlook for Cell-Tissue Culture Reagents
95% match

The 2025-2030 World Outlook for Cell-Tissue Culture Reagents

Out of Stock 18 Jun 2026
The 2025-2030 World Outlook for Cancer Vaccines
95% match

The 2025-2030 World Outlook for Cancer Vaccines

Out of Stock 19 Jun 2026
The 2013-2018 Outlook for Cell-Based Assays in the United States
95% match

The 2013-2018 Outlook for Cell-Based Assays in the United States

£495.00 12 Jun 2026
The 2023-2028 Outlook for Cancer Screenings in China
95% match

The 2023-2028 Outlook for Cancer Screenings in China

£495.00 11 Jun 2026
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in China
95% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in China

£495.00 13 Jun 2026
The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India
95% match

The 2023-2028 Outlook for Cancer Diagnostics Laboratory Tests in India

£515.00 13 Jun 2026
The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean
95% match

The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean

£425.00 19 Jun 2026